This formula contains a highly concentration of lyophilized thymus tissue concentrate in combination with pure vitamins and chelated minerals to assist in the support of normal thymus response in related functions.
The Thymus extract provides the body with specific nutritional facts that will encourage the reduction of the sympathetic endocrine and centeral nervous system activity. Also, the nutrients that are in the ingredients present in this formula will assist the fast metabolic individual experiencing lowered activity of the thymus and the reticulo-endothelial system, by supplying the nucleoproteins and co-factors necessary to increase resistance and immune response.
According to legend, glandular or organotherapy, which refers to the use of animal tissues or cell preparations to improve physiologic functioning and support the natural healing process, first gained popularity in the early to mid 1900s. The idea of glandular therapy was first introduced almost 200 years ago. Thymus extracts for nutritional supplements usually come from young calves (bovine). Bovine thymus extracts are found in capsules and tablets as dietary supplements.
Thymus extract is commonly used to stimulate the immune system and to treat bone marrow failure, autoimmune disorders, chronic skin diseases, recurrent viral and bacterial infections, hepatitis, allergies, chemotherapy side effects, and cancer. Most basic and clinical research involving oral and injectable thymus extract has been conducted in Europe.
Studies in humans suggest promising results in terms of allergies, asthma, cancer, chemotherapeutic side effects, cardiomyopathy (weakening of the heart muscle), chronic obstructive pulmonary disease, HIV/AIDS, liver disease, respiratory tract infections, systemic lupus erythematosus, and tuberculosis and to stimulate the immune system However, not all study results agree, and more well designed studies are still needed in many fields.
Christ HW. [Immunomodulating therapy of psoriasis vulgaris]. Med Klin (Munich) 10-15-1999;94 Suppl 3:90-92.
Liberati AM, Ballatori E, Fizzotti M, et al. A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin’s disease in complete remission. Cancer Immunol Immunother 1988;26(1):87-93.
Fiocchi A, Borella E, Riva E, et al. Double-blind clinical trial for the evaluation of the therapeutical effectiveness of a calf thymus derivative (Thymomodulin) in children with recurrent respiratory infections. Thymus 1986;8:331-9.
Civeira MP, Castilla A, Morte S, et al. A pilot study of thymus extract in chronic non-A, non-B hepatitis. Aliment Pharmacol Ther 1989;3:395-401.
Macchiarini P, Danesi R, Del Tacca M, Angeletti CA. Effects of thymostimulin on chemotherapy-induced toxicity and long-term survival in small cell lung cancer patients. Anticancer Res 1989;9:193-6.
Tortorella C, Ottolenghi A, Moretti AM, Jirillo E, Antonaci S. Thymostimulin administration modulates polymorph metabolic pathway in patients with chronic obstructive pulmonary disease. Immunopharmacology & Immunotoxicology. 1992, 14(3):421.
Arutiunian VM, Grigorian EG. [Effectiveness of using immunomodulators in combined treatment of patients with chronic gastritis and ulcer disease]. Klin Med (Mosk) 2003;81(5):33-35.
Jablonowska E, Tchorzewski H, Lewkowicz P, et al. Reactive oxygen intermediates and serum antioxidative system in patients with chronic C hepatitis treated with IFN-alpha and thymus factor X. Arch Immunol Ther Exp (Warsz.) 2005;53(6):529-533